Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FSH Treatment Effects on Sperm Epigenetics in Oligozoospermia
NCT02605070Phase 3Terminated
- Sponsor
- Health Research Institute Hospital La Fe
- Start
- Nov 2015
- Primary completion
- Jun 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human follicle stimulating hormone in male infertility, oligozoospermia, sponsored by Health Research Institute Hospital La Fe. Started Nov 2015; status: terminated.
02
Drugs
recombinant human follicle stimulating hormone
03
Conditions
male infertilityoligozoospermia
Beyond the preview
Go deeper on NCT02605070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02605070.